Impact of separating drug sales from medical services reform on Beijing Cancer Hospital from the perspective of medical insurance data
10.3969/j.issn.1674-2982.2017.12.003
- VernacularTitle:北京市医药分开综合改革对肿瘤专科医院的影响——基于北京某肿瘤医院医保数据的实证分析
- Author:
Jia-Hua LENG
1
;
Yi LIU
;
Zhi-Shui CHEN
;
Jun GUO
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室 北京 100142
- Keywords:
Separating drug sales from medical services;
Medical service price;
Oncology;
Medical insur-ance;
Interrupted time series
- From:
Chinese Journal of Health Policy
2017;10(12):15-21
- CountryChina
- Language:Chinese
-
Abstract:
objective:To analyze the policy impact of separating drug sales from medical services on a certain oncology hospitals in Beijing,and provide the basis for further development and adjustment of the reform. Methods:Using interrupted time series segmented regression model to analyse the instant change and trend change of medical service utilization by outpatient(including tumor-specified outpatient) and overall inpatient services,especially in in-dicators of drug proportion,self-pay ratio,and so on after the reform. Results:Tumor treatment is a relative specific-ity. The proportion of previous inpatients in tumor specialized hospitals ranged between 49.31% and 49.96%, and the actual compensation rates were between 57.05% and 63.57%. In our case analysis, the expenditure of outpa-tients dropped after this reform,with RMB 4.33 monthly decline on average cost and with 2.32 percentage monthly decrease on a self-pay rate. Drug proportion was declined expectedly,and the proportion of outpatient and inpatient drugs immediately decreased by 4.63% and 2.98% respectively after the reform. Therewith consumptive material proportion was raised, and the proportion of outpatient and inpatient materials instantly increased by 0.22% and 1.17% respectively. Conclusion:As per the results of this study,the reform has weakened the economic dependence on drug income in sample hospital and reduced the burden on patients. However,tumor treatment is on rigid demand and brings about a relatively great impact on hospital's finance and medical insurance fund. The rationality regards of cost-shifting should be investigated in the long run.
